Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma

Clinical and Vaccine Immunology

Volumn 15, Issue 9, 2008, Pages 1363-1368

  Pisani, Paola ^a,g,h   Whary, Mark T ^b   Nilsson, Ingrid ^c   Sriamporn, Supannee ^d   Wadström, Torkel ^c   Fox, James G ^b,e   Ljungh, Åsa ^c   Forman, David ^f  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c LUND UNIVERSITY   (Sweden)

^d Faculty of Public Health   (Thailand)

^e Massachusetts Institute of Technology Cambridge   (United States)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h Cancer Epidemiology Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; HELICOBACTER BILIS ANTIGEN; HELICOBACTER PYLORI ANTIGEN; OUTER MEMBRANE PROTEIN; SONICATE PROTEIN; UNCLASSIFIED DRUG;

ABSORPTION; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; CROSS REACTION; DNA DETERMINATION; FEMALE; HELICOBACTER BILIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PREABSORPTION; PRIORITY JOURNAL; SERODIAGNOSIS; THAILAND;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CHOLANGIOCARCINOMA; CROSS REACTIONS; FEMALE; HELICOBACTER; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THAILAND;

EID: 51649087984     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00132-08     Document Type: Article

References (50)

1. Ananieva, O., I. Nilsson, T. Vorobjova, R. Uibo, and T. Wadström. 2002. Immune responses to bile-tolerant Helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin. Diagn. Lab. Immunol. 9:1160-1164.
2. Apostolov, E., W. Abu Al Soud, I. Nilsson, I. Kornilovs'ka, V. Usenko, V. Lyzogubov, Y. Gaydar, T. Wadström, and Å. Ljungh. 2005. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods. Scand. J. Gastroenterol. 40:96-102.
3. Burich, A., R. Hershberg, K. Waggie, W. Zeng, T. Brabb, G. Westrich, J. L. Viney, and L. Maggio-Price. 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G764-G778.
4. Castera, L., A. Pedeboscq, M. Rocha, B. Le Bail, C. Asencio, V. de Ledinghen, P. H. Bernard, C. Laurent, M. E. Lafon, M. Capdepont, P. Couzigou, P. Bioulac-Sage, C. Balabaud, F. Megraud, and A. Menard. 2006. Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study. World J. Gastroenterol. 12:7278-7284.
5. Chen, W., D. Li, R. J. Cannan, and R. S. Stubbs. 2003. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig. Liver Dis. 35:237-243.
6. Dore, M. P., G. Realdi, D. Mura, D. Y. Graham, and A. R. Sepulveda. 2002. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig. Dis. Sci. 47:1638-1643.
7. Fleiss, J. L. 1981. Statistical methods for rates and proportions. John Wiley & Sons. Inc.. New York, NY.
8. Fox, J. G. 2002. The non-Helicobacter pylori helicobacters: their' expanding role in gastrointestinal and systemic diseases. Gut 50:273-283.
9. Fox, J. G., F. E. Dewhirst, Z. Shen, Y. Feng, N. S. Taylor, B. J. Paster, R. L. Ericson, C. N. Lau, P. Correa, J. C. Araya, and I. Roa. 1998. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114:755-763.
10. Fox, J. G., X. Li, L. Yan, R. J. Cahill, R. Hurley, R. Lewis, and J. C. Murphy. 1996. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect. Immun. 64:1548-1558.
11. Fox, J. G., A. B. Rogers, M. T. Whary, N. S. Taylor, Y. Xu Feng, and S. Keys. 2004. Helicobacter bilis-associated hepatitis in outbred mice. Comp. Med. 54:571-577.
12. Fox, J. G., L. L. Yan, F. E. Dewhirst, B. J. Paster, B. Shames, J. C. Murphy, A. Hayward, J. C. Belcher, and E. N. Mendes. 1995. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J. Clin. Microbiol. 33:445-454.
13. Franklin, C. L., L. K. Riley, R. S. Livingston, C. S. Beckwith, C. L. Besch-Williford, and R. R. Hook. 1998. Enterohepatic lesions in SCID mice infected with Helicobacter bilis. Lab. Anim. Sci. 48:334-339.
14. Ge, Z., P. Doig, and J. G. Fox. 2001. Characterization of proteins in the outer membrane preparation of a murine pathogen, Helicobacter bilis. Infect. Immun. 69:3502-3506.
15. Genta, R. M., and D. Y. Graham. 1993. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand. J. Gastroenterol. 28:924-928.
16. Hoang, T. T., T. U. Wheeldon, C. Bengtsson, D. C. Phung, M. Sorberg, and M. Granstrom. 2004. Enzyme-linked immunosorbent assay for Helicobacter pylori needs adjustment for the population investigated. J. Clin. Microbiol. 42:627-630.
17. Jongsuksuntigul, P., and T. Imsomboon. 2003. Opisthorchiasis control in Thailand. Acta Trap. 88:229-232.
18. Khan, S. A., S. D. Taylor-Robinson, M. B. Toledano, A. Beck, P. Elliott, and H. C. Thomas. 2002. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 37:806-813.
19. Kitamura, T., Y. Kawamura, K. Ohkusu, T. Masaki, H. Iwashita, T. Sawa, S. Fujii, T. Okamoto, and T. Akaike. 2007. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery. J. Clin. Microbiol. 45:31-38.
20. Kobayashi, T., K. Harada, K. Miwa, and Y. Nakanuma. 2005. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig. Dis. Sci. 50:862-867.
21. Kornilovs'ka, I., I. Nilsson, M. Utt, A. Ljungh, and T. Wadström. 2002. Immunogenic proteins of Helicobacter pullomm, Helicobacter bilis. and Helicobacter hepaticus identified by two-dimensional gel electrophoresis and immunoblotting. Proteomics 2:775-783.
22. Makola, D., D. A. Peura, and S. E. Crowe. 2007. Helicobacter pylori infection and related gastrointestinal diseases. J. Clin. Gastroenterol. 41:548-558.
23. Matsukura, N., S. Yokomuro, S. Yamada, T. Tajiri, T. Sundo, T. Hadama, S. Kamiya, Z. Naito, and J. G. Fox. 2002. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn. J. Cancer Res. 93:842-847.
24. Matsumoto, T., M. Goto, H. Murakami, T. Tanaka, H. Nishiyama, E. Ono, C. Okada, E. Sawabe, M. Yagoshi, A. Yoneyama, K. Okuzumi, K. Tateda, N. Misawa, and K. Yamaguchi. 2007. Multicenter study to evaluate bloodstream infection by Helicobacter cinaedi in Japan. J. Clin. Microbiol. 45:2853-2857.
25. Maurer, K. J., M. M. Ihrig, A. B. Rogers, V. Ng, G. Bouchard, M. R. Leonard, M. C. Carey, and J. G. Fox. 2005. Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128:1023-1033.
26. Maurer, K. J., V. P. Rao, Z. Ge, A. B. Rogers, T. J. Oura, M. C. Carey, and J. G. Fox. 2007. T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology 133:1304-1315.
27. Maurer, K. J., A. B. Rogers, Z. Ge, A. J. Wiese, M. C. Carey, and J. G. Fox. 2006. Helicobacter pylori and cholesterol gallstone formation in C57L/J. mice: a prospective study. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G175-G182.
28. Nandakumar, A., P. C. Gupta, P. Gangadharan, R. N. Visweswara, and D. M. Parkin. 2005. Geographic pathology revisited: development of an atlas of cancer in India. Int. J. Cancer 116:740-754.
29. Nilsson, H. O., U. Stenram, I. Ihse, and T. Wadstrom. 2006. Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J. Gastroenterol. 12:3038-3043.
30. Nilsson, H. O., J. Taneera, M. Castedal, E. Glatz, R. Olsson, and T. Wadström. 2000. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J. Clin. Microbiol. 38:1072-1076.
31. Nilsson, L, I. Kornilovs'ka, S. Lindgren, A. Ljungh, and T. Wadström. 2003. Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease. J. Med. Microbiol. 52:949-953.
32. Nilsson, L, Å. Ljungh, P. Aleljungh, and T. Wadström. 1997. Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J. Clin. Microbiol. 35:427-432.
33. Osawa, H., F. Inoue, and Y. Yoshida. 1996. Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia. J. Clin. Pathol. 49:112-115.
34. Pineros, D. M., S. C. Riveros, J. D. Marin, O. Ricardo, and O. Diaz. 2001. Helicobacter pylori in gastric cancer and peptic ulcer disease in a Colombian population. Strain heterogeneity and antibody profiles. Helicobacter 6:199-206.
35. Pronovost, A. D., S. L. Rose, J. W. Pawlak, H. Robin, and R. Schneider. 1994. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results. J. Clin. Microbiol. 32:46-50.
36. Randi, G., S. Franceschi, and C. La Vecchia. 2006. Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 118:1591-1602.
37. Rocha, M., P. Avenaud, A. Ménard, B. Le Bail, C. Balabaud, P. Bioulac-Sage, D. M. de Magalháesq Ueiroz, and F. Mégraud. 2005. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 54:396-401.
38. Rudi, J., A. Rudy, M. Maiwald, and W. Stremmel. 1999. Helicobacter sp. are not detectable in bile from German patients with biliary disease. Gastroenterology 116:1016-1017.
39. Shaib, Y. H., J. A. Davila, K. McGlynn, and H. B. El-Serag. 2004. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J. Hepatol. 40:472-477.
40. Shomer, N. H., C. A. Dangler, M. D. Schrenzel, and J. G. Fox. 1997. Helicobacter bilis-induced inflammatory bowel disease in SCID mice with defined flora. Infect. Immun. 65:4858-4864.
41. Sitas, F., R. Smallwood, D. Jewell, P. R. Millard, D. G. Newell, S. G. Meuwissen, S. Moses, A. Zwiers, and D. Forman. 1993. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol. Biomarkers Prev. 2:119-123.
42. Sriamporn, S., D. M. Parkin, P. Pisani, V. Vatanasapt, K. Suwanrungruang, P. Kamsa-ard, P. Pengsaa, O. Kritpetcharat, V. Pipitgool, and P. Vatanasapt. 2005. A prospective study of diet, lifestyle, and genetic factors and the risk of cancer in Khon Kaen Province, northeast Thailand: description of the cohort. Asian Pac. J. Cancer Prev. 6:295-303.
43. StataCorp. 2005. Stata statistical software: release 9. StataCorp. LP, College Station, TX.
44. Taylor-Robinson, S. D., M. B. Toledano, S. Arora, T. J. Keegan, S. Hargreaves, A. Beck, S. A. Khan, P. Flliott, and H. C. Thomas. 2001. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48:816-820.
45. Tolia, V., H. O. Nilsson, K. Boyer, A. Wuerth, W. A. Al-Soud, R. Rabah, and T. Wadström. 2004. Detection of Helicobacter ganmani-Uke 16S rDNA in pediatric liver tissue. Helicobacter 9:460-468.
46. Tzonou, A., J. Kaldor, P. G. Smith, N. E. Day, and D. Trichopoulos. 1986. Misclassification in case-control studies with two dichotomous risk factors. Rev. Epidemiol. Sante Publique 34:10-17.
47. Utt, M., I. Nilsson, Å. Ljungh, and T. Wadström. 2002. Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J. Immunol. Methods 259:1-10.
48. Veijola, L., I. Nilsson, L. Halme, W. A. Al-Soud, J. Mäkinen, A. Ljungh, and H. Rautelin. 2007. Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann. Med. 39:554-560.
49. Vorobjova, T., I. Nilsson, S. Terjajev, M. Granholm, M. Lyyra, T. Porkka, T. Prükk, R. Salupere, H.-I. Maaroos, T. Wadström, and R. Uibo. 2006. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection. Dig. Liver Dis. 38:171-176.
50. Whary, M. T., N. Suudina, L. E. Bravo, P. Correa, F. Quinones, F. Caro, and J. G. Fox. 2005. Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 14:1464-1469.